<DOC>
	<DOCNO>NCT01472120</DOCNO>
	<brief_summary>In peripheral blood ; monocyte macrophage find two phenotype ; proinflammatory M1 anti-inflammatory M2 phenotype . M2 form convert ( polarize ) M1 phenotype various metabolic disorder obesity type 2 diabetes mellitus .</brief_summary>
	<brief_title>Adiponectin Circulating Macrophage Phenotypes Non-alcoholic Fatty Liver Disease ( NAFLD )</brief_title>
	<detailed_description>In peripheral blood ; monocyte macrophage find two phenotype ; proinflammatory M1 anti-inflammatory M2 phenotype . M2 form convert ( polarize ) M1 phenotype various metabolic disorder obesity type 2 diabetes mellitus . In addition , form also related insulin resistance inflammation adipose tissue . Today , study investigate role adiponectin anti-inflammatory adipokine , macrophage polarization non-alcoholic fatty liver disease .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Persistently ( least 6 month ) elevate aminotransferase Ultrasonographic presence bright liver without liver biliary tract disease Liver histology compatible diagnosis NASH SS A history alcohol consumption &gt; 40 g/wk , assess detailed interview extend family member Morbid obesity [ body mass index ( BMI ) ≥40 kg/m2 ] , hypertension Positive blood marker viral , autoimmune , celiac disease Abnormal copper metabolism thyroid function test A diagnosis T2DM systemic arterial hypertension Total cholesterol ( TC ) ≥250 mg/dL , triglyceride ( TG ) ≥400 mg/dL , exposure occupational hepatotoxin drug know affect glucose lipid metabolism</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>